Share Price and Basic Stock Data
Last Updated: January 20, 2026, 11:28 pm
| PEG Ratio | -9.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Garware Synthetics Ltd operates in the textiles sector, specifically focusing on manmade fibres, particularly nylon. The company’s market capitalization stood at ₹9.19 Cr with a share price of ₹15.80. Over the past several quarters, the company reported fluctuating sales figures, with a high of ₹2.99 Cr in September 2022 and a subsequent decline to ₹2.47 Cr in September 2023. Sales for the trailing twelve months (TTM) reached ₹10.74 Cr, reflecting a modest decrease from ₹11.40 Cr in March 2023. The quarterly operating profit margin (OPM) has shown variability, with the most recent figure recorded at 10.92% for September 2025, indicating a recovery from lower margins seen in earlier quarters. The company’s sales have been erratic, which could signify challenges in demand or market positioning within the competitive textiles industry.
Profitability and Efficiency Metrics
Garware Synthetics reported a net profit of ₹0.15 Cr, translating to an earnings per share (EPS) of ₹0.02 for March 2025. The operating profit for the same period stood at ₹0.05 Cr, with an OPM of 0.47%, reflecting a significant decline when compared to the previous fiscal year where the OPM was 7.46%. The interest coverage ratio (ICR) was reported at 3.06 times, indicating that the company can comfortably meet its interest obligations. However, the return on capital employed (ROCE) declined to -3.05%, a stark contrast to the positive ROCE of 113.97% in March 2023. The cash conversion cycle (CCC) deteriorated to -73.69 days, signalling potential inefficiencies in managing working capital. Overall, the profitability metrics present a mixed picture, with some signs of recovery but ongoing concerns regarding operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Garware Synthetics reveals a challenging financial position, with total borrowings amounting to ₹5.40 Cr against reserves of -₹7.54 Cr as of September 2025. The company’s debt-to-equity ratio stands at -2.61, indicating a heavily leveraged position, which may raise concerns among investors regarding financial stability. The current ratio is notably low at 0.16, suggesting potential liquidity issues. The book value per share is reported at -₹3.38, further indicating financial distress. Despite these challenges, the interest coverage ratio of 3.06x suggests that the company can cover its interest expenses, although the negative reserves present a significant risk. Overall, while Garware Synthetics has some liquidity to manage its debts, the overall financial health requires careful scrutiny.
Shareholding Pattern and Investor Confidence
As of March 2025, Garware Synthetics has a shareholding pattern comprising 45.78% held by promoters, 0.01% by domestic institutional investors (DIIs), and 54.22% by the public. The number of shareholders has gradually decreased from 13,635 in December 2022 to 13,373 in September 2025, indicating a potential decline in investor confidence. The stable promoter ownership suggests a commitment to the company, but the negligible stake from DIIs may reflect a lack of institutional interest, which could be viewed as a red flag. Moreover, the public ownership of over 54% indicates a broad retail base, yet the declining number of shareholders may point to dissatisfaction with performance. This shareholding structure raises questions about the company’s ability to attract new investments while maintaining existing shareholder confidence.
Outlook, Risks, and Final Insight
Looking ahead, Garware Synthetics faces several risks that could impact its operations and financial performance. The volatility in sales and profitability metrics indicates potential issues in market demand and operational efficiency. Additionally, the high debt levels, coupled with negative reserves, pose a significant risk to financial stability. However, the company’s ability to maintain a positive interest coverage ratio suggests it can manage its immediate financial obligations. For investors, the key will be observing whether Garware Synthetics can stabilize its sales and improve its profitability metrics while managing its debt effectively. Should the company successfully navigate these challenges, there could be a recovery in investor sentiment, but failure to address these issues may lead to further declines in performance and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Garware Synthetics Ltd | 10.6 Cr. | 18.3 | 39.8/11.8 | 70.9 | 2.98 | 0.00 % | 3.05 % | % | 10.0 |
| Industry Average | 0 Cr | 18.30 | 70.90 | 2.98 | 0.00% | 3.05% | 0% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.99 | 2.74 | 2.75 | 2.89 | 2.47 | 2.72 | 2.61 | 2.67 | 2.77 | 2.55 | 2.75 | 2.60 | 2.84 |
| Expenses | 2.84 | 2.58 | 2.69 | 2.65 | 2.39 | 2.54 | 2.74 | 2.63 | 2.70 | 2.49 | 2.86 | 2.35 | 2.53 |
| Operating Profit | 0.15 | 0.16 | 0.06 | 0.24 | 0.08 | 0.18 | -0.13 | 0.04 | 0.07 | 0.06 | -0.11 | 0.25 | 0.31 |
| OPM % | 5.02% | 5.84% | 2.18% | 8.30% | 3.24% | 6.62% | -4.98% | 1.50% | 2.53% | 2.35% | -4.00% | 9.62% | 10.92% |
| Other Income | 0.03 | 0.02 | 0.54 | 0.00 | 0.01 | 0.00 | 0.28 | 0.19 | 0.07 | 0.01 | 0.29 | 0.00 | 0.00 |
| Interest | 0.08 | 0.10 | 0.06 | 0.09 | 0.17 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | -0.04 | 0.02 | 0.02 |
| Depreciation | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| Profit before tax | -0.02 | -0.03 | 0.43 | 0.04 | -0.19 | 0.02 | -0.01 | 0.07 | -0.02 | -0.10 | 0.11 | 0.12 | 0.18 |
| Tax % | -150.00% | 0.00% | -46.51% | 175.00% | 5.26% | -100.00% | -1,600.00% | 0.00% | -250.00% | 0.00% | 90.91% | 0.00% | 33.33% |
| Net Profit | 0.00 | -0.03 | 0.63 | -0.03 | -0.20 | 0.03 | 0.14 | 0.07 | 0.03 | -0.10 | 0.01 | 0.12 | 0.12 |
| EPS in Rs | 0.00 | -0.05 | 1.08 | -0.05 | -0.34 | 0.05 | 0.24 | 0.12 | 0.05 | -0.17 | 0.02 | 0.21 | 0.21 |
Last Updated: December 26, 2025, 8:16 pm
Below is a detailed analysis of the quarterly data for Garware Synthetics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2.84 Cr.. The value appears strong and on an upward trend. It has increased from 2.60 Cr. (Jun 2025) to 2.84 Cr., marking an increase of 0.24 Cr..
- For Expenses, as of Sep 2025, the value is 2.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.35 Cr. (Jun 2025) to 2.53 Cr., marking an increase of 0.18 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from 0.25 Cr. (Jun 2025) to 0.31 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Sep 2025, the value is 10.92%. The value appears strong and on an upward trend. It has increased from 9.62% (Jun 2025) to 10.92%, marking an increase of 1.30%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.11 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.11 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Jun 2025) to 0.18 Cr., marking an increase of 0.06 Cr..
- For Tax %, as of Sep 2025, the value is 33.33%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Jun 2025) to 33.33%, marking an increase of 33.33%.
- For Net Profit, as of Sep 2025, the value is 0.12 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.12 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.21. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.43 | 8.10 | 7.90 | 8.54 | 9.60 | 10.64 | 9.11 | 8.27 | 12.70 | 11.40 | 10.70 | 10.73 | 10.74 |
| Expenses | 7.86 | 8.22 | 7.81 | 8.11 | 9.10 | 10.61 | 8.81 | 7.21 | 11.73 | 10.55 | 10.32 | 10.68 | 10.23 |
| Operating Profit | -0.43 | -0.12 | 0.09 | 0.43 | 0.50 | 0.03 | 0.30 | 1.06 | 0.97 | 0.85 | 0.38 | 0.05 | 0.51 |
| OPM % | -5.79% | -1.48% | 1.14% | 5.04% | 5.21% | 0.28% | 3.29% | 12.82% | 7.64% | 7.46% | 3.55% | 0.47% | 4.75% |
| Other Income | 0.51 | 0.79 | 0.29 | 0.28 | 0.00 | -1.18 | 0.00 | 0.00 | 0.44 | 0.30 | 0.29 | 0.57 | 0.30 |
| Interest | 0.00 | 0.16 | 0.14 | 0.16 | 0.09 | 0.20 | 0.09 | 0.43 | 0.59 | 0.33 | 0.37 | 0.11 | 0.06 |
| Depreciation | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.26 | 0.47 | 0.44 | 0.44 | 0.44 |
| Profit before tax | 0.03 | 0.49 | 0.22 | 0.53 | 0.39 | -1.38 | 0.18 | 0.61 | 0.56 | 0.35 | -0.14 | 0.07 | 0.31 |
| Tax % | -200.00% | -24.49% | 27.27% | 11.32% | 10.26% | 0.00% | 38.89% | 4.92% | 58.93% | -62.86% | -71.43% | 71.43% | |
| Net Profit | 0.09 | 0.61 | 0.17 | 0.47 | 0.34 | -1.37 | 0.11 | 0.58 | 0.23 | 0.58 | -0.05 | 0.01 | 0.15 |
| EPS in Rs | 1.05 | 0.29 | 0.81 | 0.59 | -2.36 | 0.19 | 1.00 | 0.40 | 1.00 | -0.09 | 0.02 | 0.27 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 577.78% | -72.13% | 176.47% | -27.66% | -502.94% | 108.03% | 427.27% | -60.34% | 152.17% | -108.62% | 120.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -649.91% | 248.60% | -204.13% | -475.28% | 610.97% | 319.24% | -487.62% | 212.52% | -260.79% | 228.62% |
Garware Synthetics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 3% |
| 3 Years: | -5% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 98% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 67% |
| 3 Years: | 13% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:31 pm
Balance Sheet
Last Updated: December 4, 2025, 2:56 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.55 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 |
| Reserves | -9.94 | -8.26 | -8.09 | -7.63 | -7.28 | -8.66 | -8.55 | -7.96 | -8.37 | -7.78 | -7.89 | -7.78 | -7.54 |
| Borrowings | 5.97 | 4.58 | 4.52 | 4.42 | 10.16 | 12.43 | 12.91 | 12.42 | 11.99 | 5.96 | 5.39 | 5.22 | 5.40 |
| Other Liabilities | 11.20 | 10.48 | 10.46 | 10.37 | 4.89 | 4.05 | 3.17 | 3.44 | 7.49 | 11.33 | 11.21 | 11.02 | 10.52 |
| Total Liabilities | 12.78 | 12.61 | 12.70 | 12.97 | 13.58 | 13.63 | 13.34 | 13.71 | 16.92 | 15.32 | 14.52 | 14.27 | 14.19 |
| Fixed Assets | 10.73 | 10.43 | 10.43 | 10.42 | 10.50 | 10.47 | 10.45 | 10.44 | 13.53 | 12.28 | 11.84 | 11.43 | 11.25 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.05 | 2.18 | 2.27 | 2.55 | 3.08 | 3.16 | 2.89 | 3.27 | 3.39 | 3.04 | 2.68 | 2.84 | 2.94 |
| Total Assets | 12.78 | 12.61 | 12.70 | 12.97 | 13.58 | 13.63 | 13.34 | 13.71 | 16.92 | 15.32 | 14.52 | 14.27 | 14.19 |
Below is a detailed analysis of the balance sheet data for Garware Synthetics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.81 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.81 Cr..
- For Reserves, as of Sep 2025, the value is -7.54 Cr.. The value appears to be improving (becoming less negative). It has improved from -7.78 Cr. (Mar 2025) to -7.54 Cr., marking an improvement of 0.24 Cr..
- For Borrowings, as of Sep 2025, the value is 5.40 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 5.22 Cr. (Mar 2025) to 5.40 Cr., marking an increase of 0.18 Cr..
- For Other Liabilities, as of Sep 2025, the value is 10.52 Cr.. The value appears to be improving (decreasing). It has decreased from 11.02 Cr. (Mar 2025) to 10.52 Cr., marking a decrease of 0.50 Cr..
- For Total Liabilities, as of Sep 2025, the value is 14.19 Cr.. The value appears to be improving (decreasing). It has decreased from 14.27 Cr. (Mar 2025) to 14.19 Cr., marking a decrease of 0.08 Cr..
- For Fixed Assets, as of Sep 2025, the value is 11.25 Cr.. The value appears to be declining and may need further review. It has decreased from 11.43 Cr. (Mar 2025) to 11.25 Cr., marking a decrease of 0.18 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2.94 Cr.. The value appears strong and on an upward trend. It has increased from 2.84 Cr. (Mar 2025) to 2.94 Cr., marking an increase of 0.10 Cr..
- For Total Assets, as of Sep 2025, the value is 14.19 Cr.. The value appears to be declining and may need further review. It has decreased from 14.27 Cr. (Mar 2025) to 14.19 Cr., marking a decrease of 0.08 Cr..
However, the Borrowings (5.40 Cr.) are higher than the Reserves (-7.54 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.40 | -4.70 | -4.43 | -3.99 | -9.66 | -12.40 | -12.61 | -11.36 | -11.02 | -5.11 | -5.01 | -5.17 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39.30 | 36.05 | 43.43 | 38.04 | 49.43 | 40.48 | 44.07 | 64.88 | 48.28 | 47.07 | 43.32 | 48.98 |
| Inventory Days | 59.95 | 61.08 | 71.96 | 96.49 | 83.69 | 68.89 | 82.49 | 101.66 | 52.43 | 49.52 | 56.10 | 52.84 |
| Days Payable | 232.20 | 207.83 | 234.95 | 238.30 | 137.14 | 121.47 | 142.42 | 166.53 | 115.56 | 115.18 | 145.10 | 175.52 |
| Cash Conversion Cycle | -132.96 | -110.70 | -119.56 | -103.77 | -4.02 | -12.10 | -15.85 | 0.01 | -14.84 | -18.59 | -45.67 | -73.69 |
| Working Capital Days | -222.05 | -172.14 | -170.03 | -142.32 | -69.58 | -42.88 | -26.04 | -575.97 | -376.78 | -219.00 | -227.19 | -420.79 |
| ROCE % | -27.22% | 41.51% | 6.41% | 26.86% | 8.50% | 3.61% | 2.73% | 10.18% | 10.56% | 6.86% | -1.37% | -3.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.02 | -0.08 | 1.00 | 0.40 | 1.00 |
| Diluted EPS (Rs.) | 0.02 | -0.08 | 1.00 | 0.40 | 1.00 |
| Cash EPS (Rs.) | 0.77 | 0.67 | 1.80 | 0.85 | 1.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -3.38 | -3.58 | -3.39 | -4.42 | -3.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -3.38 | -3.58 | -3.39 | -4.42 | -3.71 |
| Revenue From Operations / Share (Rs.) | 18.47 | 18.42 | 19.63 | 21.86 | 14.23 |
| PBDIT / Share (Rs.) | 0.58 | 0.66 | 1.60 | 2.24 | 1.83 |
| PBIT / Share (Rs.) | -0.17 | -0.08 | 0.79 | 1.78 | 1.79 |
| PBT / Share (Rs.) | 0.11 | -0.24 | 0.60 | 0.95 | 1.05 |
| Net Profit / Share (Rs.) | 0.02 | -0.08 | 0.99 | 0.39 | 1.00 |
| PBDIT Margin (%) | 3.17 | 3.63 | 8.16 | 10.23 | 12.84 |
| PBIT Margin (%) | -0.92 | -0.47 | 4.05 | 8.16 | 12.58 |
| PBT Margin (%) | 0.63 | -1.34 | 3.09 | 4.38 | 7.36 |
| Net Profit Margin (%) | 0.12 | -0.44 | 5.07 | 1.81 | 7.05 |
| Return on Networth / Equity (%) | -0.66 | 0.00 | -29.39 | -8.97 | -27.06 |
| Return on Capital Employeed (%) | 24.30 | -0.89 | 113.97 | 94.53 | 9.86 |
| Return On Assets (%) | 0.09 | -0.32 | 3.77 | 1.36 | 4.28 |
| Long Term Debt / Equity (X) | -0.03 | -0.07 | -0.12 | -0.12 | -5.76 |
| Total Debt / Equity (X) | -2.61 | -2.55 | -5.94 | -4.67 | -5.76 |
| Asset Turnover Ratio (%) | 0.74 | 0.71 | 0.70 | 0.83 | 0.61 |
| Current Ratio (X) | 0.16 | 0.26 | 0.17 | 0.18 | 0.83 |
| Quick Ratio (X) | 0.10 | 0.16 | 0.11 | 0.11 | 0.49 |
| Inventory Turnover Ratio (X) | 12.36 | 6.41 | 6.79 | 6.94 | 3.52 |
| Interest Coverage Ratio (X) | 3.06 | 1.06 | 2.83 | 2.20 | 2.46 |
| Interest Coverage Ratio (Post Tax) (X) | -1.38 | 0.12 | 2.09 | 1.20 | 2.35 |
| Enterprise Value (Cr.) | 21.23 | 14.89 | 16.26 | 20.34 | 15.43 |
| EV / Net Operating Revenue (X) | 1.98 | 1.39 | 1.43 | 1.60 | 1.87 |
| EV / EBITDA (X) | 62.38 | 38.30 | 17.46 | 15.64 | 14.54 |
| MarketCap / Net Operating Revenue (X) | 1.51 | 0.91 | 0.42 | 0.66 | 0.36 |
| Price / BV (X) | -8.24 | -4.72 | -2.45 | -3.31 | -1.42 |
| Price / Net Operating Revenue (X) | 1.51 | 0.91 | 0.42 | 0.66 | 0.36 |
| EarningsYield | 0.00 | 0.00 | 0.12 | 0.02 | 0.19 |
After reviewing the key financial ratios for Garware Synthetics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.02, marking an increase of 0.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.02, marking an increase of 0.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 3. It has increased from 0.67 (Mar 24) to 0.77, marking an increase of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -3.38. It has increased from -3.58 (Mar 24) to -3.38, marking an increase of 0.20.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -3.38. It has increased from -3.58 (Mar 24) to -3.38, marking an increase of 0.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 18.47. It has increased from 18.42 (Mar 24) to 18.47, marking an increase of 0.05.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 2. It has decreased from 0.66 (Mar 24) to 0.58, marking a decrease of 0.08.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.17. This value is below the healthy minimum of 0. It has decreased from -0.08 (Mar 24) to -0.17, marking a decrease of 0.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.11. This value is within the healthy range. It has increased from -0.24 (Mar 24) to 0.11, marking an increase of 0.35.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 2. It has increased from -0.08 (Mar 24) to 0.02, marking an increase of 0.10.
- For PBDIT Margin (%), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 10. It has decreased from 3.63 (Mar 24) to 3.17, marking a decrease of 0.46.
- For PBIT Margin (%), as of Mar 25, the value is -0.92. This value is below the healthy minimum of 10. It has decreased from -0.47 (Mar 24) to -0.92, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 10. It has increased from -1.34 (Mar 24) to 0.63, marking an increase of 1.97.
- For Net Profit Margin (%), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has increased from -0.44 (Mar 24) to 0.12, marking an increase of 0.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.66. This value is below the healthy minimum of 15. It has decreased from 0.00 (Mar 24) to -0.66, marking a decrease of 0.66.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 24.30, marking an increase of 25.19.
- For Return On Assets (%), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from -0.32 (Mar 24) to 0.09, marking an increase of 0.41.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -0.03. This value is below the healthy minimum of 0.2. It has increased from -0.07 (Mar 24) to -0.03, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.61. This value is within the healthy range. It has decreased from -2.55 (Mar 24) to -2.61, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.74. It has increased from 0.71 (Mar 24) to 0.74, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 1.5. It has decreased from 0.26 (Mar 24) to 0.16, marking a decrease of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.16 (Mar 24) to 0.10, marking a decrease of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.36. This value exceeds the healthy maximum of 8. It has increased from 6.41 (Mar 24) to 12.36, marking an increase of 5.95.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.06. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 3.06, marking an increase of 2.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.38. This value is below the healthy minimum of 3. It has decreased from 0.12 (Mar 24) to -1.38, marking a decrease of 1.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 21.23. It has increased from 14.89 (Mar 24) to 21.23, marking an increase of 6.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.98, marking an increase of 0.59.
- For EV / EBITDA (X), as of Mar 25, the value is 62.38. This value exceeds the healthy maximum of 15. It has increased from 38.30 (Mar 24) to 62.38, marking an increase of 24.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.51, marking an increase of 0.60.
- For Price / BV (X), as of Mar 25, the value is -8.24. This value is below the healthy minimum of 1. It has decreased from -4.72 (Mar 24) to -8.24, marking a decrease of 3.52.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.51, marking an increase of 0.60.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Garware Synthetics Ltd:
- Net Profit Margin: 0.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.3% (Industry Average ROCE: 3.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.66% (Industry Average ROE: 0%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.38
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 70.9 (Industry average Stock P/E: 70.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.61
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Manmade Fibre - Nylon | Manish Textiles Industrial Premises, Opposite Golden Chemical, Thane District Maharashtra 401104 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sunder K Moolya | Whole Time Director |
| Mr. Deepak P Kamble | Executive Director |
| Mr. Harish Shriyan | Ind. Non-Executive Director |
| Mr. Sandip K Pawar | Ind. Non-Executive Director |
| Mrs. Shital Kamble | Ind. Non-Executive Director |
| Mr. Nihal Garware | Non Exe.Non Ind.Director |
| Mrs. Shipla S Parab | Ind. Non-Executive Woman Director |
FAQ
What is the intrinsic value of Garware Synthetics Ltd?
Garware Synthetics Ltd's intrinsic value (as of 21 January 2026) is ₹23.91 which is 30.66% higher the current market price of ₹18.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹10.6 Cr. market cap, FY2025-2026 high/low of ₹39.8/11.8, reserves of ₹-7.54 Cr, and liabilities of ₹14.19 Cr.
What is the Market Cap of Garware Synthetics Ltd?
The Market Cap of Garware Synthetics Ltd is 10.6 Cr..
What is the current Stock Price of Garware Synthetics Ltd as on 21 January 2026?
The current stock price of Garware Synthetics Ltd as on 21 January 2026 is ₹18.3.
What is the High / Low of Garware Synthetics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Garware Synthetics Ltd stocks is ₹39.8/11.8.
What is the Stock P/E of Garware Synthetics Ltd?
The Stock P/E of Garware Synthetics Ltd is 70.9.
What is the Book Value of Garware Synthetics Ltd?
The Book Value of Garware Synthetics Ltd is 2.98.
What is the Dividend Yield of Garware Synthetics Ltd?
The Dividend Yield of Garware Synthetics Ltd is 0.00 %.
What is the ROCE of Garware Synthetics Ltd?
The ROCE of Garware Synthetics Ltd is 3.05 %.
What is the ROE of Garware Synthetics Ltd?
The ROE of Garware Synthetics Ltd is %.
What is the Face Value of Garware Synthetics Ltd?
The Face Value of Garware Synthetics Ltd is 10.0.